Page last updated: 2024-09-03

ly 274614 and nalbuphine

ly 274614 has been researched along with nalbuphine in 1 studies

Compound Research Comparison

Studies
(ly 274614)
Trials
(ly 274614)
Recent Studies (post-2010)
(ly 274614)
Studies
(nalbuphine)
Trials
(nalbuphine)
Recent Studies (post-2010) (nalbuphine)
96015793269185

Protein Interaction Comparison

ProteinTaxonomyly 274614 (IC50)nalbuphine (IC50)
Mu-type opioid receptorHomo sapiens (human)0.0578
Delta-type opioid receptorHomo sapiens (human)1.1195
Kappa-type opioid receptorHomo sapiens (human)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dykstra, LA; Fischer, BD1

Other Studies

1 other study(ies) available for ly 274614 and nalbuphine

ArticleYear
Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:3

    Topics: Analgesics, Opioid; Animals; Buprenorphine; Butorphanol; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Hot Temperature; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Morphine; N-Methylaspartate; Nalbuphine; Receptors, Opioid

2006